Skip to content

Author

C. Kamiya-Matsuoka

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Nov 2026

PATH-68 Clinical and molecular features of synchronous and metachronous primary brain tumors

Primary brain tumors (PBTs) are uncommon among the general population. Molecularly distinct PBTs in the same individual are even rarer and generally occur in the context of specific well-characterized hereditary cancer syndromes or in exposure to high-risk environmental factors such as remote CNS irradiation. In...

Aditya Pisupati, J. Wefel, S. Bajaj et al. · 0 citations
Review Open access Nov 2026

BIOM-40 Molecular Profiles of Long-Term Survivors with Unmethylated MGMT Glioblastoma

Unmethylated MGMT promoter status occurs in 60% of glioblastoma (GBM) cases, driving active DNA-repair enzyme production, severe temozolomide resistance, and a dismal median overall survival under 16 months. Despite this poor prognosis, a rare subset of unmethylated GBM (uMGMT-GBM) patients achieve unexpected lon...

Marine Isakadze, Serena Cutarella, J. Wefel et al. · 0 citations
Review Open access Oct 2026

MEK inhibitors in NF1-associated high-grade glioma: partial responses and outcomes from a single-institution cohort and literature review

NF1-associated high-grade gliomas (HGGs) are rare, biologically heterogeneous tumors with poor outcomes. Although MEK inhibitors (MEKis) are established options for selected NF1-associated low-grade gliomas, their role in NF1-associated HGG remains undefined. We describe clinical and radiographic outcomes with MEKis, i...

Ming-Chun Yu, Aileen H. Hsi, Aqsa Adnan et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.